John K. Cini - 25 May 2021 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role: Chief Scientific Officer
Signature: /s/ John Harry Cross III, power of attorney
Issuer symbol: SONN
Transactions as of: 25 May 2021
Net transactions value: -$21,146
Form type: 4
Filing time: 28 May 2021, 16:00:43 UTC
Next filing: 08 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SONN	Common Stock	Tax liability	$21,146	-14,004	-5.9%	$1.51	224,067	25 May 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold by the Issuer in multiple transactions at prices ranging from $1.49 to $1.55 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Content

The price reported in Column 4 is a weighted average price. These shares were sold by the Issuer in multiple transactions at prices ranging from $1.49 to $1.55 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.